Anti-inflammatory nanoparticles significantly improve muscle function in a murine model of advanced muscular dystrophy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-inflammatory nanoparticles significantly improve muscle function in a murine model of advanced muscular dystrophy
Authors
Keywords
-
Journal
Science Advances
Volume 7, Issue 26, Pages eabh3693
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-06-24
DOI
10.1126/sciadv.abh3693
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
- (2020) Tuo Wei et al. Nature Communications
- Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy
- (2020) Nicolas J. Abreu et al. PEDIATRIC PULMONOLOGY
- CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells
- (2019) Yi-Li Min et al. Science Advances
- Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
- (2019) Christopher E. Nelson et al. NATURE MEDICINE
- Preclinical studies evaluate pivotal TNFα nanomedicine clinical trial design.
- (2019) Naris Nilubol et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy
- (2019) Lindsay N. Alfano et al. MEDICINE
- Automated optimized parameters for T-distributed stochastic neighbor embedding improve visualization and analysis of large datasets
- (2019) Anna C. Belkina et al. Nature Communications
- CD4 T-cells regulate angiogenesis and myogenesis
- (2018) Brian J. Kwee et al. BIOMATERIALS
- Eteplirsen treatment for Duchenne muscular dystrophy
- (2018) Jay S. Charleston et al. NEUROLOGY
- Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
- (2018) Leonela Amoasii et al. SCIENCE
- Functional muscle recovery with nanoparticle-directed M2 macrophage polarization in mice
- (2018) Theresa M. Raimondo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CRISPR/Cas9-Mediated Genome Editing Corrects Dystrophin Mutation in Skeletal Muscle Stem Cells in a Mouse Model of Muscle Dystrophy
- (2017) Pei Zhu et al. Molecular Therapy-Nucleic Acids
- Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
- (2017) Kunwoo Lee et al. Nature Biomedical Engineering
- Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype
- (2016) Joana Capote et al. JOURNAL OF CELL BIOLOGY
- Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors
- (2016) Aung Naing et al. JOURNAL OF CLINICAL ONCOLOGY
- Biologic-free mechanically induced muscle regeneration
- (2016) Christine A. Cezar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors
- (2016) Yoshitsugu Aoki et al. Drug Design Development and Therapy
- Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis
- (2015) Elisabetta Gazzerro et al. AMERICAN JOURNAL OF PATHOLOGY
- Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds
- (2015) Kara L. Spiller et al. BIOMATERIALS
- The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
- (2015) Catherine L. Bladen et al. HUMAN MUTATION
- Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors
- (2015) Dario R Lemos et al. NATURE MEDICINE
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
- (2015) C. E. Nelson et al. SCIENCE
- Immune-mediated pathology in Duchenne muscular dystrophy
- (2015) Amy S. Rosenberg et al. Science Translational Medicine
- PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
- (2014) Peter V. Hornbeck et al. NUCLEIC ACIDS RESEARCH
- Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy
- (2014) S. A. Villalta et al. Science Translational Medicine
- A Special Population of Regulatory T Cells Potentiates Muscle Repair
- (2013) Dalia Burzyn et al. CELL
- Anti-Dystrophin T Cell Responses in Duchenne Muscular Dystrophy: Prevalence and a Glucocorticoid Treatment Effect
- (2013) Kevin M. Flanigan et al. HUMAN GENE THERAPY
- Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy
- (2013) Boel De Paepe et al. MEDIATORS OF INFLAMMATION
- Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
- (2013) N. Kamaly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A new model of experimental fibrosis in hindlimb skeletal muscle of adult mdx mouse mimicking muscular dystrophy
- (2012) Isabelle Desguerre et al. MUSCLE & NERVE
- PKC Theta Ablation Improves Healing in a Mouse Model of Muscular Dystrophy
- (2012) Luca Madaro et al. PLoS One
- Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
- (2011) Carl D. Walkey et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human Trials
- (2011) Zejing Wang et al. Frontiers in Microbiology
- Nonresolving Inflammation
- (2010) Carl Nathan et al. CELL
- AAV-directed muscular dystrophy gene therapy
- (2010) Ying Tang et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype
- (2010) S. A. Villalta et al. HUMAN MOLECULAR GENETICS
- Identification of a novel muscle targeting peptide in mdx mice
- (2010) Yiqi Seow et al. PEPTIDES
- Size and Shape of Protein Molecules at the Nanometer Level Determined by Sedimentation, Gel Filtration, and Electron Microscopy
- (2009) Harold P. Erickson BIOLOGICAL PROCEDURES ONLINE
- Current status and challenges of cytokine pharmacology
- (2009) Z Zídek et al. BRITISH JOURNAL OF PHARMACOLOGY
- Interleukin-10: new perspectives on an old cytokine
- (2009) David M. Mosser et al. IMMUNOLOGICAL REVIEWS
- STAT6 Activation Confers upon T Helper Cells Resistance to Suppression by Regulatory T Cells
- (2009) B. B. L. Pillemer et al. JOURNAL OF IMMUNOLOGY
- Synthesis and Surface Modification of Highly Monodispersed, Spherical Gold Nanoparticles of 50−200 nm
- (2009) Steven D. Perrault et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors
- (2009) Cristina Borselli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started